I am a scientist with 12 years of research experience with extensive training in the fields of molecular diagnostics, immunology, and nanomedicine.
Currently as a PhD candidate at Baylor College of Medicine, I work in a lab interested in developing groundbreaking treatments for autoimmune diseases. During my dissertation research, I have defined a new direction for my lab: using bleeding-edge carbon nanoparticles to treat rheumatoid arthritis and multiple sclerosis. My efforts led to the filing of a non-provisional utility patent application.
I believe that while basic science research is pivotal for treating diseases, the strategic advancement and commercialization of novel findings play a crucial role as well. To that end, I worked as a consultant intern for Fannin Innovation Studio, a venture capital firm and life science accelerator, to gain a complete understanding of the drug development process and learn about the business aspects of science.
Previously, I worked as an R&D scientist at Canon U.S. Life Sciences, a subsidiary of Canon, Inc. As a part of an interdisciplinary team consisting of biologists, engineers, physicists and computer scientists, we built clinical genotyping assays and transitioned them onto our in-house microfluidic platform with the goal of manufacturing a medical device that would detect genetic diseases from patient samples within minutes. I was fortunate enough to be a part of the team that conducted the first field trial of the device with collaborators across the US.
In all my professional endeavors, colleagues have known me as a dedicated problem solver—I always aim to identify the core issue, work with the most crucial information, and propose a solution in the shortest time.
I am intensely passionate about my career and its growth. Using my diverse experiences from the private sector and academia, I am always looking for opportunities to attain the maximum possible significance and impact from my knowledge and contributions.